Sangivamycin
Sangivamycin (NSC 65346), a nucleoside analog, is a potent inhibitor of protein kinase C (PKC) with an Ki of 10 μM. Sangivamycin has potent antiproliferative activity against a variety of human cancers[1][2].
Product Specifications
CAS Number
18417-89-5
Product Name Alternative
NSC 65346; BA-90912
UNSPSC
12352005
Hazard Statement
H300
Target
Nucleoside Antimetabolite/Analog; PKC
Type
Natural Products
Related Pathways
Cell Cycle/DNA Damage; Epigenetics; TGF-beta/Smad
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/sangivamycin.html
Concentration
10mM
Purity
97.68
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
OC[C@@H]1[C@@H](O)[C@@H](O)[C@H](N2C3=NC=NC(N)=C3C(C(N)=O)=C2)O1
Molecular Formula
C12H15N5O5
Molecular Weight
309.28
Precautions
H300
References & Citations
[1]Loomis CR, Bell RM. Sangivamycin, a nucleoside analogue, is a potent inhibitor of protein kinase C. J Biol Chem. 1988;263 (4) :1682-1692.|[2]Lee SA, et al. The nucleoside analog sangivamycin induces apoptotic cell death in breast carcinoma MCF7/adriamycin-resistant cells via protein kinase Cdelta and JNK activation. J Biol Chem. 2007;282 (20) :15271-15283.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Natural Products
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15270212 1 Vial
Lentiviral mouse Dvl1 shRNA (UAS) - Lentiviral mouseDvl1 shRNA (UAS, GFP) (25)
Sign In for Pricing
View Details 
LV664643 1.0 µg DNA
N4BP2L2 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC)
Sign In for Pricing
View Details K6764204 1.0 µg DNA
Gata6 sgRNA CRISPR Lentivector (Rat) (Target 3)
Sign In for Pricing
View Details